This Article Full Text Full Text (PDF) All Versions of this Article: 91/11/e35    most recent 01.RES.0000046017.96083.34v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kintscher, U. Articles by Law, R. E. Search for Related Content PubMed PubMed Citation Articles by Kintscher, U. Articles by Law, R. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Cell signalling/signal transduction Gene expression Growth factors/cytokines Smooth muscle proliferation and differentiation Mechanism of atherosclerosis/growth factors

(Circulation Research. 2002;91:e35.)
© 2002 American Heart Association, Inc.

UltraRapid Communication

PPAR Inhibits TGF-ß–Induced ß₅ Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad4

Ulrich Kintscher, Christopher Lyon, Shu Wakino, Dennis Bruemmer, Xu Feng, Stephan Goetze, Kristof Graf, Aristidis Moustakas, Bart Staels, Eckart Fleck, Willa A. Hsueh, Ronald E. Law

From the Department of Medicine (U.K., C.L., S.W., D.B., W.A.H., R.E.L.), Division of Endocrinology, Diabetes and Hypertension, University of California, Los Angeles, School of Medicine, Los Angeles, Calif; Institute of Pharmacology and Toxicology (U.K.), Charité Hospital, Humboldt-University Berlin, Berlin, Germany; the Department of Medicine/Cardiology (D.B., S.G., K.G., E.F.), German Heart Institute Berlin, Berlin, Germany; the Department of Pathology (X.F.), University of Alabama, Birmingham, Ala; Ludwig Institute for Cancer Research (A.M.), Uppsala, Sweden; the Department d’Atherosclerose (B.S.), UR545 INSERM, Institut Pasteur de Lille and Faculté de Pharmacie, Universitè de Lille II, Lille, France.

Correspondence to Ronald E. Law, PhD, UCLA School of Medicine, Division of Endocrinology, Diabetes and Hypertension, Warren Hall, Second Floor, Suite 24-130, 900 Veteran Ave, Box 957073, Los Angeles, CA 90095. E-mail rlaw{at}mednet.ucla.edu

Integrins play an important role in vascular smooth muscle cell (VSMC) migration, a crucial event in the development of restenosis and atherosclerosis. Transforming growth factor-ß (TGF-ß) is highly expressed in restenotic and atherosclerotic lesions, and known to induce integrin expression. Peroxisome proliferator-activated receptor (PPAR), a member of the nuclear receptor superfamily, regulates gene expression in a variety of vascular cells. We investigated the effects of PPAR ligands on TGF-ß–induced ß₃ and ß₅ integrin expression and potential interaction between PPAR and TGF-ß signaling. PPAR ligands WY-14643 (100 µmol/L) and 5,8,11,14-eicosatetranoic acid (ETYA, 50 µmol/L) inhibited TGF-ß–induced ß₅ integrin protein expression by 72±6.8% and 73±7.1%, respectively (both P<0.05). TGF-ß–stimulated ß₃ integrin expression was not affected by PPAR ligands. Both PPAR ligands also suppressed TGF-ß–induced ß₅ integrin mRNA levels. PPAR ligands inhibited TGF-ß–inducible transcription of ß₅ integrin by an interaction with a TGF-ß response element between nucleotides -63 and -44, which contains a Sp1/Sp3 transcription factor binding site. Nuclear complexes binding to the TGF-ß response region contained Sp1/Sp3 and TGF-ß–regulated Smad 2, 3, and 4 transcription factors. TGF-ß–stimulated Sp1/Smad4 nuclear complex formation was inhibited by WY-14643 and ETYA with a parallel induction of PPAR/Smad4 interactions. However, in vitro pull-down experiments failed to demonstrate direct binding between PPAR/Smad4. Both PPAR ligands blocked PDGF-directed migration of TGF-ß–pretreated VSMCs, a process mediated, in part, by ß₅ integrins. The present study demonstrates that PPAR activators inhibit TGF-ß–induced ß₅ integrin transcription in VSMCs through a novel indirect interaction between ligand-activated PPAR and the TGF-ß–regulated Smad4 transcription factors. The full text of this article is available at http://www.circresaha.org.

Key Words: peroxisome proliferator-activated receptor • integrin • transforming growth factor-ß • vascular smooth muscle cell

This article has been cited by other articles:

				X. Ruan, F. Zheng, and Y. Guan PPARs and the kidney in metabolic syndrome Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1032 - F1047. [Abstract] [Full Text] [PDF]

				K. Sekiguchi, Q. Tian, M. Ishiyama, J. Burchfield, F. Gao, D. L. Mann, and P. M. Barger Inhibition of PPAR-{alpha} activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta/Smad3 Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1443 - H1451. [Abstract] [Full Text] [PDF]

				T. Ichijo, A. Voutetakis, A. P. Cotrim, N. Bhattachryya, M. Fujii, G. P. Chrousos, and T. Kino The Smad6-Histone Deacetylase 3 Complex Silences the Transcriptional Activity of the Glucocorticoid Receptor: POTENTIAL CLINICAL IMPLICATIONS J. Biol. Chem., December 23, 2005; 280(51): 42067 - 42077. [Abstract] [Full Text] [PDF]

				M. Schupp, M. Clemenz, R. Gineste, H. Witt, J. Janke, S. Helleboid, N. Hennuyer, P. Ruiz, T. Unger, B. Staels, et al. Molecular Characterization of New Selective Peroxisome Proliferator-Activated Receptor {gamma} Modulators With Angiotensin Receptor Blocking Activity Diabetes, December 1, 2005; 54(12): 3442 - 3452. [Abstract] [Full Text] [PDF]

				Y. Guan Peroxisome Proliferator-Activated Receptor Family and Its Relationship to Renal Complications of the Metabolic Syndrome J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2801 - 2815. [Abstract] [Full Text] [PDF]

				M. Schupp, J. Janke, R. Clasen, T. Unger, and U. Kintscher Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator-Activated Receptor-{gamma} Activity Circulation, May 4, 2004; 109(17): 2054 - 2057. [Abstract] [Full Text] [PDF]